Robert Dumitrescu, Marc Matar, Rainer Opgen-Rhein, Samuel Calderwood
Advertisement
Robert Dumitrescu, Partner, Simon-Kucher & Partners (Paris)Dr. Marc Matar, Partner, Simon-Kucher & Partners (London)Dr. Dr. Rainer Opgen-Rhein, Senior Director, Simon-Kucher & Partners (Munich)Dr. Samuel Calderwood, Consultant, Simon-Kucher & Partners (London)
Articles by Robert Dumitrescu, Marc Matar, Rainer Opgen-Rhein, Samuel Calderwood
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What FDA's AI Warning Letter Tells Us About GMP Accountability
2
Why Are Drugmakers Racing to Acquire ADC Payload Platforms?
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
The Evolving World of Counterfeit Drugs...Where Does Serialization Fit?
5